(Bloomberg) — Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsIs Trumpâs Plan to Reopen the Notorious Alcatraz Prison Realistic?Whatâs Behind the Rise in Serious Injuries on New York Cityâs Streets?NYC Warns ofRead More
